SCHEMBL9894981

SCHEMBL9894981

CS(=O)(=O)c1ccc(C(Cc2ccc(F)cc2Cl)C(=O)Nc2nc3ccccc3o2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 1/20 0.39
FFAR2 O15552 1/20 0.39
AKT1 P31749 1/20 0.39
PIK3CA P42336 1/20 0.39
MTOR P42345 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
TP53 P04637 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
GCK P35557 3/20 0.37
KMT2A Q03164 2/20 0.37
MAPT P10636 1/20 0.37
FBP1 P09467 1/20 0.37
PTGS2 P35354 1/20 0.36
GALK1 P51570 2/20 0.36
CTSS P25774 1/20 0.36
S1PR1 P21453 1/20 0.35
S1PR3 Q99500 1/20 0.35
NR1H2 P55055 1/20 0.35
NR1H3 Q13133 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9895051 0.89 CSNK1D (0.43) CSNK1DFFAR2NPC1RAB9ATP53
SCHEMBL9895818 0.86 PTPN1 (0.45) CSNK1DFFAR2NPC1RAB9ATP53
SCHEMBL9895023 0.86 PTPN1 (0.45) CSNK1DFFAR2NPC1RAB9ATP53
SCHEMBL9894908 0.86 NPC1 (0.41) CSNK1DFFAR2NPC1RAB9ATP53
SCHEMBL9896932 0.85 NPC1 (0.42) CSNK1DFFAR2NPC1RAB9ATP53
SCHEMBL9894873 0.85 NPC1 (0.42) CSNK1DFFAR2NPC1RAB9ATP53
SCHEMBL9894874 0.85 NPC1 (0.42) CSNK1DFFAR2NPC1RAB9ATP53
SCHEMBL9895215 0.81 NPC1 (0.44) CSNK1DFFAR2NPC1RAB9ATP53
SCHEMBL9896000 0.81 AKT1 (0.43) FFAR2AKT1PIK3CAMTORGCK
SCHEMBL9894828 0.80 FFAR2 (0.45) FFAR2AKT1PIK3CAMTORTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120149718-A1 Amido Compounds BROTHERTON-PLEISS CHRISTINE E (US) 2012-06-14 US claimed
US-20120149718-A1 Amido Compounds BROTHERTON-PLEISS CHRISTINE E (US) 2012-06-14 US disclosed
US-20120149718-A1 Amido Compounds BROTHERTON-PLEISS CHRISTINE E (US) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149718-A1 Amido Compounds P2RX7, P2RX3, P2RX2 CSNK1D 2063/4885FFAR2 236/4885AKT1 3167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.